Current Neuro-Oncology

Volume 26 Number 6
31 March 2024

Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 6, 31 March

Jang B, Yoon D, Lee JY, Kim J, Hong J, Koo H, Sa JK.
Integrative multi-omics characterization reveals sex differences in glioblastoma.
Biol Sex Differ. 2024 Mar 16;15(1):23. doi: 10.1186/s13293-024-00601-7. PMID: 38491408. Observational study. ˍ

*Zhu P, Pichardo-Rojas PS, Dono A, Tandon N, Hadjipanayis CG, Berger MS, Esquenazi Y.
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
J Neurooncol. 2024 Mar 16. doi: 10.1007/s11060-024-04644-z. PMID: 38492191. Observational study˰ ˍ

*Cao W, Lan J, Hu C, Kong J, Xiang L, Zhang Z, Sun Y, Zeng Z, Lei S.
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Aging (Albany NY). 2024 Mar 18;16. doi: 10.18632/aging.205668. PMID: 38499392. Observational study. ˍ

Nemati M, Shayanfar M, Almasi F, Mohammad-Shirazi M, Sharifi G, Aminianfar A, Esmaillzadeh A.
Dietary patterns in relation to glioma: a case-control study.
Cancer Metab. 2024 Mar 18;12(1):8. doi: 10.1186/s40170-024-00336-4. PMID: 38500219. Observational study. ˍ

Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K, Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M, Caluwaert K, Nijs G, Cools N, Verlooy J, Norga K, Verhulst S, Anguille S, Berneman Z, Lion E.
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
BMJ Open. 2024 Mar 18;14(3):e077613. doi: 10.1136/bmjopen-2023-077613. PMID: 38503417. Interventional study protocol. ˍ

*Bobholz SA, Lowman AK, Connelly JM, Duenweg SR, Winiarz A, Nath B, Kyereme F, Brehler M, Bukowy J, Coss D, Lupo JM, Phillips JJ, Ellingson BM, Krucoff MO, Mueller WM, Banerjee A, LaViolette PS.
Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement.
Neurosurgery. 2024 Mar 19. doi: 10.1227/neu.0000000000002898. PMID: 38501824. Observational study. ˍ

Geens W, Vanlaer N, Nijland L, Van Laere S, Schwarze JK, Bruneau M, Neyns B, Rogiers A, Duerinck J.
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
J Neurooncol. 2024 Mar 19. doi: 10.1007/s11060-024-04646-x. PMID: 38502281. Observational study˰ ˍ

Roth P, Gorlia T, Reijneveld JC, de Vos F, Idbaih A, Frenel JS, Le Rhun E, Sepulveda JM, Perry J, Masucci GL, Freres P, Hirte H, Seidel C, Walenkamp A, Lukacova S, Meijnders P, Blais A, Ducray F, Verschaeve V, Nicholas G, Balana C, Bota DA, Preusser M, Nuyens S, Dhermain F, van den Bent M, O'Callaghan CJ, Vanlancker M, Mason W, Weller M; EORTC Brain Tumor Group and the Canadian Cancer Trials Group.
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial.
Neuro Oncol. 2024 Mar 19:noae053. doi: 10.1093/neuonc/noae053. PMID: 38502052. Interventional study. ˍ

*Fairclough S, Chumas P, Goodden J, Maguire M, Mathew RK.
Motor seizures confer overall survival benefit in who grade 2 glioma.
Epilepsia. 2024 Mar 20. doi: 10.1111/epi.17956. PMID: 38506645. Observational study. ˍ

*Fink L, van Oorschot B, von Saß C, Dibué M, Foster MT, Golla H, Goldbrunner R, Senft C, Lawson McLean A, Hellmich M, Dinc N, Voltz R, Melching H, Jungk C, Kamp MA.
Palliative care for in-patient malignant glioma patients in Germany.
J Neurooncol. 2024 Mar 20. doi: 10.1007/s11060-024-04611-8. PMID: 38506960. Observational study. ˍ

Li MP, Yeo A, Gunewardena R, Drum G, Wiltshire K, Phillips C, Sia J, Wheeler G, Hall L.
Is proton beam therapy always better than photon irradiation? Lessons from two cases.
J Med Radiat Sci. 2024 Mar 20. doi: 10.1002/jmrs.773. PMID: 38504608. Case report. ˍ

Rejimon AC, Ramesh KK, Trivedi AG, Huang V, Schreibmann E, Weinberg BD, Kleinberg LR, Shu HG, Shim H, Olson JJ.
The Utility of Spectroscopic MRI in Stereotactic Biopsy and Radiotherapy Guidance in Newly Diagnosed Glioblastoma.
Tomography. 2024 Mar 20;10(3):428-443. doi: 10.3390/tomography10030033. PMID: 38535775. Observational study. ˍ

*Ryba A, Özdemir Z, Nissimov N, Hönikl L, Neidert N, Jakobs M, Kalasauskas D, Krigers A, Thomé C, Freyschlag CF, Ringel F, Unterberg A, Dao Trong P, Beck J, Heiland DH, Meyer B, Vajkoczy P, Onken J, Stummer W, Suero Molina E, Gempt J, Westphal M, Schüller U, Mohme M.
Insights from a Multicenter Study on Adult H3 K27M-Mutated Glioma: Surgical Resection's Limited Influence on Overall Survival, ATRX as Molecular Prognosticator.
Neuro Oncol. 2024 Mar 20:noae061. doi: 10.1093/neuonc/noae061. PMID: 38507506. Observational study˰ ˍ

*Wang J, Du Q, Chen J, Liu J, Gu Z, Wang X, Zhang A, Gao S, Shao A, Zhang J, Wang Y.
Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors.
Front Oncol. 2024 Mar 20;14:1345190. doi: 10.3389/fonc.2024.1345190. PMID: 38571508. Observational study. ˍ

Gull HH, Von Riegen AC, Beckmann GT, Ketelauri P, Walbrodt S, Santos AN, Oster C, Schmidt T, Glas M, Jabbarli R, Özkan N, Dammann P, Scheffler B, Sure U, Ahmadipour Y.
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients.
Cancers (Basel). 2024 Mar 21;16(6):1231. doi: 10.3390/cancers16061231. PMID: 38539563. Observational study. ˍ

Kim D, Lee JH, Kim N, Lim DH, Song JH, Suh CO, Wee CW, Kim IA.
Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02).
Neurosurgery. 2024 Mar 21. doi: 10.1227/neu.0000000000002903. PMID: 38511935. Observational study˰ ˍ

*Fernández-Valverde F, Bautista-Bárcena MP, Roldán-Romero E, Solivera-Vela J, Bravo-Rodríguez F, Ramos-Gómez MJ.
Prognostic value of brain perfusion by MRI in the initial study of high grade gliomas.
Radiologia (Engl Ed). 2024 Mar 22;66(2):114-120. doi: 10.1016/j.rxeng.2022.12.010. PMID: 38614528. Observational study˰ ˍ

Picca A, Touat M, Belin L, Gourmelon C, Harlay V, Cuzzubbo S, Cohen-Jonathan Moyal E, Bronnimann C, Di Stefano AL, Laurent I, Lerond J, Carpentier C, Bielle F, Ducray F, Dehais C; POLA Network.
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Eur J Cancer. 2024 Mar 22;202:114034. doi: 10.1016/j.ejca.2024.114034. PMID: 38537315. Interventional study˰ ˍ

*Straube C, Combs SE, Bernhardt D, Gempt J, Meyer B, Zimmer C, Schmidt-Graf F, Vajkoczy P, Grün A, Ehret F, Zips D, Kaul D.
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
J Neurooncol. 2024 Mar 23. doi: 10.1007/s11060-024-04633-2. PMID: 38520571. Observational study. ˍ

Desai PB, Karve A, Zawit M, Arora P, Dave N, Awosika J, Li N, Fuhrman B, Medvedovic M, Sallans L, Kendler A, DasGupta B, Plas D, Curry R, Zuccarello M, Chaudhary R, Sengupta S, Wise-Draper TM.
A Phase 0/1 Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-rade Gliomas.
Clin Cancer Res. 2024 Mar 26. doi: 10.1158/1078-0432.CCR-23-3341. PMID: 38530160. Interventional study˰ ˍ

Mak LS, Li X, Chan WYK, Leung AWK, Cheuk DKL, Yuen LYP, So JCC, Ha SY, Liu APY.
Case report: Therapy-related myeloid neoplasms in three pediatric cases with medulloblastoma.
Front Oncol. 2024 Mar 26;14:1364199. doi: 10.3389/fonc.2024.1364199. PMID: 38595820. Case report. ˍ

Meel M, Jindal A, Kumar M, Mathur K, Singh A.
IDH1, ATRX, p53, and Ki67 Expression in Glioblastoma patients: Their Clinical and Prognostic Significance-A Prospective Study.
Asian J Neurosurg. 2024 Mar 26;19(1):14-20. doi: 10.1055/s-0042-1750783. PMID: 38751398. Observational study. ˍ

Phillips MCL, Thotathil Z, Dass PH, Ziad F, Moon BG.
Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report.
Oncol Lett. 2024 Mar 26;27(5):230. doi: 10.3892/ol.2024.14363. PMID: 38586213. Case report. ˍ

Wellbrock M, Voigt M, Ronckers C, Grabow D, Spix C, Erdmann F.
Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980-2019: An analysis of 40 years based on data from the German Childhood Cancer Registry.
Pediatr Blood Cancer. 2024 Mar 26:e30954. doi: 10.1002/pbc.30954. PMID: 38532243. Observational study. ˍ

Alcazar-Felix RJ, Srinath A, Hage S, Bindal A, Ressler A, Pytel P, Allaw S, Girard R, Marchuk DA, Awad IA, Polster SP.
Pathologic Features of Brain Hemorrhage After Radiation Treatment: Case Series with Somatic Mutation Analysis.
J Stroke Cerebrovasc Dis. 2024 Mar 27:107699. doi: 10.1016/j.jstrokecerebrovasdis.2024.107699. PMID: 38552890. Observational study˰ ˍ

*Duffau H.
Case report: when art is faced with brain surgery: acute change in creative style in a painter after glioma resection.
Front Oncol. 2024 Mar 28;14:1394609. doi: 10.3389/fonc.2024.1394609. PMID: 38606096. Case report. ˍ

*Qin Z, Yang B, Jin X, Zhao H, Liu N.
Cuproptosis in glioblastoma: unveiling a novel prognostic model and therapeutic potential.
Front Oncol. 2024 Mar 28;14:1359778. doi: 10.3389/fonc.2024.1359778. PMID: 38606090. Laboratory investigation. ˍ

Troschel FM, Troschel BO, Kloss M, Jost J, Pepper NB, Völk-Troschel AS, Wiewrodt RG, Stummer W, Wiewrodt D, Eich HT.
Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients.
Strahlenther Onkol. 2024 Mar 28. doi: 10.1007/s00066-024-02225-7. PMID: 38546749. Observational study. ˍ

Evans L, Walker R, MacDiarmid J, Brahmbhatt H, Anazodo A, McCowage G, Gifford AJ, Kavallaris M, Trahair T, Ziegler DS.
A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.
Target Oncol. 2024 Mar 28. doi: 10.1007/s11523-024-01051-2. PMID: 38546944. Interventional study. ˍ

Tong E, Horsley P, Wheeler H, Wong M, Venkatesha V, Chan J, Kastelan M, Back M.
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643-0. PMID: 38551747. Observational study˰ ˍ

Juarez TM, Gill JM, Heng A, Carrillo JA, Wagle N, Nomura N, Nguyen M, Truong J, Dobrawa L, Sivakumar W, Barkhoudarian G, Kelly DF, Kesari S.
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer.
Neurooncol Adv. 2024 Mar 30;6(1):vdae049. doi: 10.1093/noajnl/vdae049. PMID: 38680990. Interventional study. ˍ

Barnett AE, Ozair A, Bamashmos AS, Li H, Bosler DS, Yeaney G, Ali A, Peereboom DM, Lathia JD, Ahluwalia MS.
MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma.
Cancers (Basel). 2024 Mar 31;16(7):1374. doi: 10.3390/cancers16071374. PMID: 38611052. Observational study. ˍ

Bieth T, Facque V, Altmayer V, Poisson I, Ovando-Tellez M, Moreno-Rodriguez S, Lopez-Persem A, Mandonnet E, Volle E.
Impaired creative cognition after surgery for an IDH-mutated glioma: A proof-of-concept study.
Cortex. 2024 Mar 31;174:219-233. doi: 10.1016/j.cortex.2024.02.017. PMID: 38593576.. Observational study. ˍ